Biomarkers and Therapeutic Targets in Inflammatory Breast Cancer (IBC) Tiffany AveryMassimo Cristofanilli Biomarkers (S Dawood, Section Editor) 16 October 2014 Pages: 245 - 250
Prognostic and Predictive Role of Circulating Tumor Cells in Breast Cancer Michal MegoJames M. Reuben Biomarkers (S Dawood, Section Editor) 25 September 2014 Pages: 251 - 259
Ki67 as a Biomarker of Prognosis and Prediction: Is it Ready for Use in Routine Pathology Practice? Constance AlbarracinSagar Dhamne Biomarkers (S Dawood, Section Editor) 28 September 2014 Pages: 260 - 266
Loco-Regional Therapy for Early and Advanced Breast Cancer in the Molecular Era Nita S. NairRajendra A. Badwe Biomarkers (S Dawood, Section Editor) 25 September 2014 Pages: 267 - 274
Emerging Prognostic and Predictive Biomarkers for Triple Negative Breast Cancer Shona NagAnupama ManeSudeep Gupta Biomarkers (S Dawood, Section Editor) 27 September 2014 Pages: 275 - 282
Management of the Axilla After Neoadjuvant Therapy: Current Data and Controversies Alexandra GangiMichael ChoiArmando E. Giuliano Clinical Trials (S Hurvitz, Section Editor) 17 October 2014 Pages: 283 - 288
Clinical Evaluation of Platinum Agents for the Treatment of Triple Negative Breast Cancer Cornelia LiedtkeAchim RodyMichael Untch Clinical Trials (S Hurvitz, Section Editor) 05 October 2014 Pages: 289 - 295